隔膜起搏治療系統市場：依產品、應用分類 - 2025-2030 年全球預測

隔膜起搏治療系統市場2023年估值為50.3億美元，預計到2024年將達到54億美元，複合年成長率為7.39%，預計到2030年將達到82.9億美元。

隔膜起搏治療系統 (DPTS) 是一項醫療創新，旨在幫助患有脊髓損傷和自主呼吸困難的 ALS 患者。這項技術涉及透過手術植入刺激隔膜的電極，使患者能夠更有效地呼吸。對 DPTS 的需求源於對機械人工呼吸器，機械呼吸器有感染疾病和生活品質下降等風險。 DPTS 可以增加患者的活動能力並提高生活品質，因此其應用在醫院和家庭護理環境中非常重要。最終用途範圍包括醫療保健設施和居家醫療服務，主要針對患有慢性呼吸道疾病的患者。 DPTS 市場的主要驅動力是醫療技術的進步、呼吸系統疾病病例的增加以及對以患者為中心的護理的日益支持。重要的成長機會在於透過政府醫療保健計劃和與保險公司合作擴大地理可近性和負擔能力。然而，高昂的成本、有限的患者和醫療保健專業人士意識以及嚴格的監管要求是顯著的挑戰。創新可以集中在非侵入性起搏技術、提高電池壽命、開發更緊湊的系統等，並旨在提高採用率並進一步納入現有的醫療通訊協定。它還可以研究個人化治療計劃和自適應起搏系統。儘管這個市場是一個以技術快速進步為特徵的動態市場，但仍需要在意識和培訓方面進行投資，以克服教育障礙並最佳化 DPTS 在傳統醫療環境中的使用。公司應制定策略，透過增加新興國家的研發力度並利用遠端醫療，確保創新滿足不斷變化的臨床需求。總體而言，透過與政府和非營利組織合作來降低成本和提高可及性，可以有效確保市場成長，並為依賴機械支援系統的患者帶來顯著利益。

市場動態：快速發展的隔膜起搏治療系統市場的關鍵市場洞察

隔膜起搏治療系統市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

• 市場促進因素
  • 脊髓損傷和肌萎縮側索硬化症 (ALS) 的發生率增加
  • 由於 DPTS 的優勢，採用率有所提高
  • 侵入性機械通氣 (IMV)併發症導致需求激增
• 市場限制因素
  • 製造業價格上漲
• 市場機會
  • 投資於產品成本效益和先進性
  • 膈肌起搏治療系統的研發活動增加
• 市場挑戰
  • 核准週期較長

波特五力：駕馭隔膜起搏治療系統市場的策略工具

波特的五力框架是了解隔膜起搏治療系統市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解隔膜起搏治療系統市場的外部影響

外部宏觀環境因素在塑造隔膜起搏治療系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解隔膜起搏治療系統市場的競爭格局

對隔膜起搏治療系統市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣隔膜起搏治療系統市場供應商的績效評估

FPNV 定位矩陣是評估隔膜起搏治療系統市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了隔膜起搏治療系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，隔膜起搏治療系統市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 脊髓損傷和肌萎縮側索硬化症 (ALS) 的發生率增加
    • 採用率的提高超過了 DPTS 的優勢
    • 侵入性人工呼吸器(IMV)併發症導致需求激增
  • 抑制因素
    • 生產成本上升
  • 機會
    • 投資於產品成本效益和先進性
    • 膈肌起搏治療系統的研發活動增加
  • 任務
    • 延長核准期限
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章隔膜起搏治療系統市場：依產品

• 隔膜心律調節器
• 心律調節器

第7章隔膜起搏治療系統市場：依應用分類

• 肌萎縮側索硬化症
• 脊髓損傷

第8章北美和南美隔膜節律治療系統市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太隔膜起搏治療系統市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章歐洲、中東和非洲隔膜起搏治療系統市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• Atrotech Oy
• Avery Biomedical Devices, Inc
• Koninklijke Philips NV
• Lungpacer Medical, Inc
• Synapse Biomedical Inc.

The Diaphragm Pacing Therapy System Market was valued at USD 5.03 billion in 2023, expected to reach USD 5.40 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 8.29 billion by 2030.

The Diaphragm Pacing Therapy System (DPTS) is a medical innovation designed to assist individuals with conditions like spinal cord injuries or ALS, which impair the ability to breathe independently. This technology involves surgically implanting electrodes that stimulate the diaphragm, allowing patients to breathe more effectively. The necessity of DPTS arises from the high demand for alternatives to mechanical ventilators, which carry risks such as infections and reduced quality of life. DPTS allows for greater patient mobility and improved life quality, making its application critical in hospitals and home care settings. End-use scope primarily involves healthcare facilities and home healthcare services catering to patients with chronic respiratory issues. The DPTS market is primarily driven by advancements in medical technology, increasing cases of respiratory disorders, and greater advocacy for patient-centric care. Significant growth opportunities lie in expanding geographic accessibility and enhancing affordability through governmental health initiatives and partnerships with insurance providers. However, high costs, limited awareness among patients and healthcare professionals, and stringent regulatory requirements are notable challenges. Innovations could focus on non-invasive pacing techniques, improving battery life, and creating more compact systems, aiming to increase adoption and further integrate into existing healthcare protocols. Research can also explore personalized therapy plans and adaptive pacing systems. The market is dynamic, characterized by rapid technological advancements, yet requires investment in awareness and training initiatives to overcome educational barriers and optimize the utilization of DPTS in more conventional medical contexts. Companies should strategize on enhancing their R&D efforts in emerging economies and leveraging telemedicine to expand their reach, ensuring that innovation aligns with evolving clinical needs. Overall, targeting cost reduction and improving accessibility through collaborations with governments and non-profits could effectively secure market growth and provide significant benefits to patients reliant on mechanical support systems.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diaphragm Pacing Therapy System Market

The Diaphragm Pacing Therapy System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of spinal cord injuries and amyotrophic lateral sclerosis (ALS)
  • Increasing adoption over advantages of DPTS
  • Demand upsurge due to invasive mechanical ventilation (IMV) complications
• Market Restraints
  • High prices for production
• Market Opportunities
  • Investment for the cost-effectiveness and advancement of product
  • Increase in R&D activities across Diaphragm Pacing Therapy System
• Market Challenges
  • Prolonged approval period

Porter's Five Forces: A Strategic Tool for Navigating the Diaphragm Pacing Therapy System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diaphragm Pacing Therapy System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diaphragm Pacing Therapy System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diaphragm Pacing Therapy System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diaphragm Pacing Therapy System Market

A detailed market share analysis in the Diaphragm Pacing Therapy System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diaphragm Pacing Therapy System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diaphragm Pacing Therapy System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diaphragm Pacing Therapy System Market

A strategic analysis of the Diaphragm Pacing Therapy System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diaphragm Pacing Therapy System Market, highlighting leading vendors and their innovative profiles. These include Atrotech Oy, Avery Biomedical Devices, Inc, Koninklijke Philips N.V., Lungpacer Medical, Inc, and Synapse Biomedical Inc..

Market Segmentation & Coverage

This research report categorizes the Diaphragm Pacing Therapy System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diaphragm Pacemaker and External Diaphragm Pacemaker.
• Based on Application, market is studied across Amyotrophic Lateral Sclerosis and Spinal Cord Injury.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of spinal cord injuries and amyotrophic lateral sclerosis (ALS)
    • 5.1.1.2. Increasing adoption over advantages of DPTS
    • 5.1.1.3. Demand upsurge due to invasive mechanical ventilation (IMV) complications
  • 5.1.2. Restraints
    • 5.1.2.1. High prices for production
  • 5.1.3. Opportunities
    • 5.1.3.1. Investment for the cost-effectiveness and advancement of product
    • 5.1.3.2. Increase in R&D activities across Diaphragm Pacing Therapy System
  • 5.1.4. Challenges
    • 5.1.4.1. Prolonged approval period
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diaphragm Pacing Therapy System Market, by Product

• 6.1. Introduction
• 6.2. Diaphragm Pacemaker
• 6.3. External Diaphragm Pacemaker

7. Diaphragm Pacing Therapy System Market, by Application

• 7.1. Introduction
• 7.2. Amyotrophic Lateral Sclerosis
• 7.3. Spinal Cord Injury

8. Americas Diaphragm Pacing Therapy System Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Diaphragm Pacing Therapy System Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Diaphragm Pacing Therapy System Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Atrotech Oy
• 2. Avery Biomedical Devices, Inc
• 3. Koninklijke Philips N.V.
• 4. Lungpacer Medical, Inc
• 5. Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. DIAPHRAGM PACING THERAPY SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DIAPHRAGM PACING THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DIAPHRAGM PACING THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIAPHRAGM PACING THERAPY SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIAPHRAGM PACING THERAPY SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY DIAPHRAGM PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY EXTERNAL DIAPHRAGM PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. CANADA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CHINA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. INDIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ITALY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. POLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. QATAR DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM DIAPHRAGM PACING THERAPY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. DIAPHRAGM PACING THERAPY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. DIAPHRAGM PACING THERAPY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023